RARA CRAFT DATABASE for FDA Medical Devices
PMAP150035S003

FDA DEVICE FACTS

Aveir DR Leadless System

ABBOTT MEDICAL

Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。

DECISION DATEJune 29, 2023PRODUCT CODEPNJ

Indications for use

The Aveir DR Leadless System is indicated for management of one or more of the following permanent conditions: x Syncope x Pre-syncope x Fatigue x Disorientation Rate-Modulated Pacing is indicated for patients with chronotropic incompetence, and for those who would benefit from increased stimulation rates concurrent with physical activity. Dual-Chamber Pacing is indicated for patients exhibiting: x Sick sinus syndrome x Chronic, symptomatic second- and third-degree AV block x Recurrent Adams-Stokes syndrome x Symptomatic bilateral bundle branch block when tachyarrhythmia and other causes have been ruled out Atrial Pacing is indicated for patients with: x Sinus node dysfunction and normal AV and intraventricular conduction systems Ventricular Pacing is indicated for patients with: x Significant bradycardia and normal sinus rhythm with only rare episodes of AV block or sinus arrest x Chronic atrial fibrillation x Severe physical disability MR Conditional: Aveir Leadless Pacemaker is conditionally safe for use in the MRI environment when used according to the instructions in the Abbott MRI-Ready Leadless System Manual. Aveir Delivery Catheter: The Aveir Delivery Catheter is intended to be used in the peripheral vasculature and the cardiovascular system to deliver and manipulate an LP. PMA P150035-S003: FDA Summary of Safety and Effectiveness Data 2 of 56

Delivery and manipulation includes implanting an LP within the target chamber of the heart. Aveir Link Module: The Aveir Link Module is intended to be used in conjunction with a Merlin™ PCS Programmer to in terrogate and program an Aveir LP and to monitor LP function during an implant, retrieval, or follow-up procedure.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 2, 2026